SHORT HILLS, N.J., Oct. 30 /PRNewswire-USNewswire/ -- COLORBLENDS will donate a portion of the proceeds generated from the sale of its "Spring Forward" daffodil collection to the Christopher and Dana Reeve Foundation (CDRF), the national, non-profit organization dedicated to finding treatments and cures for spinal cord injury and improving the lives of people living with paralysis.
The Spring Forward collection, available from COLORBLENDS online and through its 2007 catalog, is a complimentary blend of two hardy, deer resistant daffodils for autumn planting. One is glowing yellow with a broad orange cup. The other is a double with soft yellow petals interspersed with flecks of reddish orange. In a sunny, well-drained location, these perennials will brighten the spring landscape for many years to come. COLORBLENDS will donate 40% of the purchase price to the search for a cure for paralysis.
"Christopher and Dana Reeve worked tirelessly to improve the lives of people living with paralysis," said Tim Schipper, owner of COLORBLENDS. "We are honored to join in the quest for a cure for paralysis and help improve the quality of life for those individuals and families living with it. We hope proceeds from the Spring Forward collection will help the Foundation continue to provide help and hope far beyond the daffodil season."
COLORBLENDS delivers premium quality, top-sized daffodil, tulip, crocus, amaryllis, and hyacinth bulbs direct from the Netherlands at wholesale prices. This third-generation, family owned company invests a great amount of effort developing and testing new flowerbulb blends and evaluating new varieties, many of which are available right now.
"We are delighted that COLORBLENDS is supporting the Christopher and
Dana Reeve Foundation with their Spring Forward collection," said Peter
Wilderotter, President. "We are so appreciative for COLORBLENDS support of
Chris' and Dana's mission and for commemorating their amazing lives and
'/>"/>
| SOURCE Christopher and Dana Reeve Foundation Copyright©2007 PR Newswire. All rights reserved |